MedTrace Logo

Black Raspberry Nectar for the Prevention of Lung Cancer, BE WELL Study

NCT04267874 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2023-12-01

No results posted yet for this study

Summary

This trial studies how well black raspberry nectar works in changing the gut microbiome and in reducing inflammatory processes that may lead to lung cancer. Studying the effects of black raspberry beverage on inflammation may help doctors find strategies to reduce the risk of developing lung cancer.

Conditions

  • Lung Carcinoma
  • Tobacco-Related Carcinoma

Interventions

PROCEDURE

Biospecimen Collection

Undergo collection of nasal swabs, blood, urine, and stool

DIETARY_SUPPLEMENT

Nutritional Supplementation

Given black raspberry nectar PO

DRUG

Placebo Administration

Given PO

OTHER

Questionnaire Administration

Ancillary studies

Sponsors & Collaborators

  • Ohio State University Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Daniel Spakowicz, PhD, MS · Ohio State University Comprehensive Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
55 Years
Max Age
77 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-25
Primary Completion
2021-05-13
Completion
2021-06-13
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04267874 on ClinicalTrials.gov